Transo-Pharm and Hapila expand Estriol production capacity

Transo-Pharm and Hapila expand cooperation

1/12/2022

March 10, 2022 UPDATE: Please find here a new press release on Pharmaceutical-Networking !

Transo-Pharm Handels-GmbH and HAPILA GmbH are determined to deepen their relationship and have therefore jointly decided to expand the production capacities at the HAPILA site in Gera, mainly to meet the increasing demand for the active ingredient Estriol Micronized.

The planning for the construction and installation work started in 2020.

The new facility is expected to be completed in 2022.

For more information please download attachements (German or English available).